Arizona: Big Pharma's Anti-Marijuana Stance Aims to Squash the Competition, Activists Say

As marijuana legalization swept the US in November, Arizona was alone in its rejection of legal weed. There, a pharmaceutical company called Insys was a major backer of the successful campaign to stop the state’s recreational cannabis measure, publicly arguing that pot businesses would be bad for public health and endanger children.

But to marijuana activists, the motive of Insys was clear – to squash the competition.

Confirming those suspicions, Insys has now received approval from the US Drug Enforcement Administration (DEA) to develop its own synthetic marijuana, the latest case of Big Pharma battling small cannabis growers.

Could a marijuana tax help Portland's minority-owned businesses? Read more

With marijuana now legal in more than half of the US, the budding cannabis industry and longtime underground players have grown increasingly concerned about...

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: